Hybrid Iron Oxide-Graphene Oxide-Polysaccharides Microcapsule: A Micro-Matryoshka for On-Demand Drug Release and Antitumor Therapy In Vivo

ACS Appl Mater Interfaces. 2016 Mar 23;8(11):6859-68. doi: 10.1021/acsami.6b00322. Epub 2016 Mar 14.

Abstract

Premature drug release is a common drawback in stimuli-responsive drug delivery systems (DDS), especially if it depends on internal triggers, which are hard to control, or a single external stimulus, which can only have one function. Thus, many DDS systems have been reported that combined different triggers; however, limited success has been established in fine-tuning the release process, mainly due to the poor bioavailability and complexity of the reported designs. This paper reports the design of a hybrid microcapsule (h-MC) by a simple layer-by-layer technique comprising polysaccharides (sodium alginate, chitosan, and hyaluronic acid), iron oxide, and graphene oxide (GO). Electrostatic assembly of the oppositely charged polysaccharides and graphene sheets provided a robust structure in which to load drugs through pH control. The polysaccharide component ensured high biocompatibility, bioavailability, and tumor cells targeting. The alternative magnetic field and near-infrared laser triggerable Fe3O4@GO component provided for dual high-energy and high-penetration hyperthermia therapy. On-demand drug release from h-MC can be achieved by synchronizing these external triggers, making the release highly controllable. The synergistic effect of hyperthermia and chemotherapy was successfully confirmed in vitro and in vivo.

Keywords: layer-by-layer; magnetic hyperthermia; microcapsules; on-demand release; photothermal therapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Capsules
  • Delayed-Action Preparations / chemistry
  • Delayed-Action Preparations / pharmacokinetics
  • Delayed-Action Preparations / pharmacology
  • Ferric Compounds* / chemistry
  • Ferric Compounds* / pharmacokinetics
  • Ferric Compounds* / pharmacology
  • Graphite* / chemistry
  • Graphite* / pharmacokinetics
  • Graphite* / pharmacology
  • HeLa Cells
  • Humans
  • Hyperthermia, Induced / methods*
  • Mice
  • Mice, Inbred BALB C
  • Mice, Nude
  • Neoplasms, Experimental / pathology
  • Neoplasms, Experimental / therapy*
  • Xenograft Model Antitumor Assays

Substances

  • Capsules
  • Delayed-Action Preparations
  • Ferric Compounds
  • ferric oxide
  • Graphite